Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-10-16

FDA Approved: RISPERIDONE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved an original abbreviated new drug application for risperidone by Zydus Lifesciences Limited, enabling the sale of a generic risperidone product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

ORIG AP for RISPERIDONE (RISPERIDONE)